Continuing rapid expansion, Thermo Fisher says it will add on plasmid DNA manufacturing site in California
It’s been a whirlwind week for Thermo Fisher.
Over the course of five days prior to Wednesday, the Massachusetts CDMO had announced two major expansion projects across the globe, both of which will increase the company’s footprint in the vaccine marketplace. And now, Thermo has unveiled a third major expansion project — this time, a new cGMP facility specializing in the production of plasmid DNA at its Carlsbad, California site.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.